A new ovarian cancer surveillance test is now being offered to women with an inherited risk of the disease, marking a significant development in care. University College London Hospitals NHS ...

A common blood test for ovarian cancer is more likely to fall short for Black and Native American women, according to a new study. This was the case for Nefa-Tari Moore, 45, a three time "thriver" of ...

Cancerguard screens for 50 types of cancer with one blood test. Doctors explain the accuracy, benefits and limits of ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health ...

You might hear about your risk of ovarian cancer through an aunt, mother, sister or grandmother. For some, there are no signs of hereditary cancer in the family, but genetic testing still reveals a ...

Screening tests check for a condition, like cancer, in people who don’t have any signs or symptoms. There aren’t any standard screening tests for ovarian cancer if you’re at average risk. The best ...

Treatments for platinum-resistant ovarian cancer are expanding with new FDA-approved immunotherapy combinations and targeted ...

A breakthrough targeted therapy, mirvetuximab soravtansine, is offering new hope to women with hard-to-treat ovarian cancer.

June 4 (Reuters) - The UK cost-effectiveness watchdog on Thursday recommended AbbVie's "guided missile" cancer therapy, ...